Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens
A 45-year-old woman presented to the Moran Eye Center in 2002 for correction of high myopia, with SE of −11.75 in the right eye and −7.75 in the left eye. Verisyse pIOLs were implanted in both eyes, 4 months apart, in the FDA Verisyse clinical trial. Postoperative CDVA was 20/20 in the right eye and 20/25+2 in the left. Ten years later, on routine follow-up, the patient reported decreased vision in the right eye, with a CDVA of 20/60. Slit-lamp examination identified nuclear sclerosis in the right eye. The patient subsequently underwent pIOL explantation and cataract extraction, with PCIOL placement in the right eye. At the last examination, 1 year after pIOL removal, CDVA was 20/20+, and SE was −0.75 in the right eye. The patient has reported no problems post-pIOL in the left eye.